Document › Details
ActeaVentures GmbH. (10/1/14). "Press Release: Norito Kaneda, Ph.D. Joins ActeaVentures as Associate Partner Based in Japan". Kobe.
|Organisation 2||Eli Lilly Japan K.K.|
|Group||Eli Lilly (Group)|
|Person||Kaneda, Norito (ActeaVentures 201410– Associate Partner in JP + CEO of PharmaConnect Co Ltd before Lilly)|
|Person 2||Peukert, Uwe (ActeaVentures 201403– Managing Partner before Roche + Lilly + Onyx + NewVac)|
ActeaVentures GmbH is pleased to welcome Norito Kaneda, Ph.D as Associate Partner. Dr. Kaneda joins ActeaVentures following a career of more than 30 years in the pharmaceutical and biotech industry. He will be the Head of ActeaVentures’ Kobe, Japan, based office and operations.
Dr. Kaneda previously held roles as a “Manager of Research Acquisition” and “Sr. Research Scientist” in the Global External R&D group at Lilly Research Laboratories, Japan. Prior to this role in BD&L, he worked as “Head, System Propulsion Group” in the R&D Dept. at Eli Lilly Japan, as “Head, Analytical Development Lab.”, Eli Lilly Japan. Prior to his 22 years’ tenure at Eli Lilly & Co., he had worked as “Research Scientist, Pharmacognosy” at Univ. Illinois at Chicago (USA) for three years. Before that, as a Researcher in the Central Research Lab. and Assistant Manager in the R&D Dept. at SS Pharmaceutical Co. For two years Dr. Kaneda has assumed the role as “Visiting Scholar, Pharmacognosy” at the Graduate school at Univ. of Minnesota (USA).
Dr. Kaneda will continue to serve as President and CEO of PharmaConncet Co. Ltd, a BD&L advisory firm for life science projects which he has previously founded.
Dr. Kaneda holds a Ph.D. in Pharmacognosy (1987) from the Dept. of Pharmacy, College of Medicine, Hiroshima University (Hiroshima, Japan), as well as a B.S. in Pharmacy (1976) from the College of Pharmacy, Fukuoka University, (Fukuoka, Japan) and an M.S. in Pharmacognosy (1978) from the Dept. of Pharmacy, College of Medicine, Hiroshima University, (Hiroshima, Japan).
“Norito is a highly respected and well renounced Pharmaceutical BD&L professional with deep experience and unrivaled connections in the Japanese, South Korean and Taiwanese markets." says Uwe Peukert, one of ActeaVentures’ Managing Partners. “Besides his deep BD&L experience, scientific knowledge and outstanding network Norito is a great person to work with. It is an honor to have him on board and we look forward to making his unique expertise and skill set available to our clients.”
ActeaVentures is a global business development advisory firm for the Life Sciences Industry with operations in Europe, Asia and the US. With offices in Berlin, Boston, Karlsruhe, Kobe, Lyon, Madrid, San Francisco, Shanghai and Singapore, ActeaVentures offers its clients comprehensive services for licensing and M&A projects in Pharma, Biotech, Diagnostics and Medtech. ActeaVentures’ team consists of Senior Business Development professionals with strong track records in deal making, having successfully served big pharma, medium-sized and biotech companies. ActeaVenturs GmbH (www.acteaventures.com) is privately held and registered in Karlsruhe, Germany.
Record changed: 2016-03-20
More documents for ActeaVentures GmbH
-  Neovacs S.A.. (2/21/17). "Press Release: Neovacs and BioSense Sign Option Agreement Worth up to €65 Million plus Royalties for Chinese Development and Commercial Rights to IFNalpha Kinoid for Lupus and Dermatomyositis". Paris....
-  ActeaVentures GmbH. (2/21/17). "Press Release: ActeaVentures Successfully Assisted Neovacs in Partnering IFN-K for Lupus to BioSense Global for the Chinese Market". Karlsruhe....
-  ActeaVentures GmbH. (3/21/14). "Press Release: ActeaVentures GmbH Launched – Offering Business Development Services for Life Science Companies". Karlsruhe et al.....
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)